{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:35:43Z","timestamp":1761896143599},"reference-count":65,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,6]],"date-time":"2015-08-06T00:00:00Z","timestamp":1438819200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Brasileira de Hematologia e Hemoterapia"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.bjhh.2015.07.011","type":"journal-article","created":{"date-parts":[[2015,8,19]],"date-time":"2015-08-19T05:16:20Z","timestamp":1439961380000},"page":"28-36","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Hematopoietic progenitor cell mobilization for autologous transplantation \u2013 a literature review"],"prefix":"10.1016","volume":"38","author":[{"given":"Marco Aur\u00e9lio","family":"Salvino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jefferson","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8852","key":"10.1016\/j.bjhh.2015.07.011_bib0330","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/0140-6736(93)92411-L","article-title":"Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial","volume":"341","author":"Linch","year":"1993","journal-title":"Lancet"},{"issue":"9323","key":"10.1016\/j.bjhh.2015.07.011_bib0335","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/S0140-6736(02)08938-9","article-title":"Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial","volume":"359","author":"Schmitz","year":"2002","journal-title":"Lancet"},{"issue":"23","key":"10.1016\/j.bjhh.2015.07.011_bib0340","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1056\/NEJM199512073332305","article-title":"Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma","volume":"333","author":"Philip","year":"1995","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.bjhh.2015.07.011_bib0345","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1200\/JCO.2003.10.023","article-title":"High-dose therapy improves progression-free survival and survival in relapsed follicular non-Hodgkin's lymphoma: results from the randomized European CUP trial","volume":"21","author":"Schouten","year":"2003","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.bjhh.2015.07.011_bib0350","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.bbmt.2006.09.010","article-title":"High-dose therapy with single autologous transplantation versus chemotherapy for newly diagnosed multiple myeloma: a systematic review and meta-analysis of randomized controlled trials","volume":"13","author":"Koreth","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.bjhh.2015.07.011_bib0355","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/bmt.2009.141","article-title":"Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009","volume":"45","author":"Ljungman","year":"2010","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1016\/j.bjhh.2015.07.011_bib0360","doi-asserted-by":"crossref","first-page":"589","DOI":"10.6004\/jnccn.2012.0061","article-title":"Hodgkin lymphoma, version 2.2012 featured updates to the NCCN guidelines","volume":"10","author":"Hoppe","year":"2012","journal-title":"J Natl Compr Canc Netw"},{"issue":"9","key":"10.1016\/j.bjhh.2015.07.011_bib0365","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.6004\/jnccn.2014.0125","article-title":"Non-Hodgkin's Lymphomas, Version 4.2014","volume":"12","author":"Zelenetz","year":"2014","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"10.1016\/j.bjhh.2015.07.011_bib0370","doi-asserted-by":"crossref","first-page":"11","DOI":"10.6004\/jnccn.2013.0004","article-title":"Multiple myeloma, version 1.2013","volume":"11","author":"Anderson","year":"2013","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"10.1016\/j.bjhh.2015.07.011_bib0375","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1053\/bbmt.2003.50002","article-title":"The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of multiple myeloma: an evidence-based review","volume":"9","author":"Hahn","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"10.1016\/j.bjhh.2015.07.011_bib0380","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.bbmt.2010.01.008","article-title":"The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of follicular lymphoma: an evidence-based review","volume":"16","author":"Oliansky","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bjhh.2015.07.011_bib0385","series-title":"Summary Slides 2014 (PowerPoint)","author":"CIBMTR, Center for International Blood and Marrow Transplant Research","year":"2014"},{"key":"10.1016\/j.bjhh.2015.07.011_bib0390","series-title":"Registro Brasileiro de Transplantes: Dimensionamento dos transplantes no Brasil e em cada estado (2006\u20132013). S\u00e3o Paulo","year":"2013"},{"issue":"8","key":"10.1016\/j.bjhh.2015.07.011_bib0395","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.bbmt.2012.01.008","article-title":"Systematic review of randomized controlled trials of hematopoietic stem cell mobilization strategies for autologous transplantation for hematologic malignancies","volume":"18","author":"Sheppard","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.bjhh.2015.07.011_bib0400","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.bbmt.2013.10.013","article-title":"Optimizing autologous stem cell mobilization strategies to improve patient outcomes: consensus guidelines and recommendations","volume":"20","author":"Giralt","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"10.1016\/j.bjhh.2015.07.011_bib0405","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1200\/JCO.2000.18.6.1360","article-title":"Therapeutic relevance of CD34 cell dose in blood cell transplantation for cancer therapy","volume":"18","author":"Siena","year":"2000","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.bjhh.2015.07.011_bib0410","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/sj.bmt.1702378","article-title":"Cost-effectiveness of CD34+ dose in peripheral blood progenitor cell transplantation for non-Hodgkin's lymphoma patients: a single centre study","volume":"25","author":"Limat","year":"2000","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"10.1016\/j.bjhh.2015.07.011_bib0415","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.exphem.2011.05.004","article-title":"In and out of the niche: perspectives in mobilization of hematopoietic stem cells","volume":"39","author":"Mohty","year":"2011","journal-title":"Exp Hematol"},{"issue":"3","key":"10.1016\/j.bjhh.2015.07.011_bib0420","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/bmt.2008.410","article-title":"Improving stem cell mobilization strategies: future directions","volume":"43","author":"Bensinger","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bjhh.2015.07.011_bib0425","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-61779-943-3_1","article-title":"Mobilization of hematopoietic stem\/progenitor cells: general principles and molecular mechanisms","volume":"904","author":"Bonig","year":"2012","journal-title":"Methods Mol Biol"},{"issue":"7","key":"10.1016\/j.bjhh.2015.07.011_bib0430","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1182\/blood.V89.7.2233","article-title":"The biology and clinical uses of blood stem cells","volume":"89","author":"To","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.bjhh.2015.07.011_bib0435","doi-asserted-by":"crossref","first-page":"312656","DOI":"10.1155\/2013\/312656","article-title":"Regulatory systems in bone marrow for hematopoietic stem\/progenitor cells mobilization and homing","volume":"2013","author":"Alvarez","year":"2013","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.bjhh.2015.07.011_bib0440","doi-asserted-by":"crossref","first-page":"835138","DOI":"10.1155\/2014\/835138","article-title":"New insights in the mobilization of hematopoietic stem cells in lymphoma and multiple myeloma patients","volume":"2014","author":"Angelopoulou","year":"2014","journal-title":"Biomed Res Int"},{"issue":"1","key":"10.1016\/j.bjhh.2015.07.011_bib0445","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/leu.2012.254","article-title":"Hematopoietic stem cell mobilization: updated conceptual renditions","volume":"27","author":"Bonig","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.bjhh.2015.07.011_bib0450","first-page":"4048","article-title":"Chemo-mobilization provides superior mobilization and collection in autologous stem cell transplants but with less predictability and at a higher cost","volume":"118","author":"Chao","year":"2011","journal-title":"Blood (ASH Annual Meeting Abstracts)"},{"issue":"4","key":"10.1016\/j.bjhh.2015.07.011_bib0455","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1200\/JCO.1998.16.4.1547","article-title":"Comparable engraftment kinetics following peripheral-blood stem-cell infusion mobilized with granulocyte colony-stimulating factor with or without cyclophosphamide in multiple myeloma","volume":"16","author":"Desikan","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bjhh.2015.07.011_bib0460","first-page":"49","article-title":"Hematopoietic stem cell mobilization with agents other than G-CSF","volume":"904","author":"Hoggatt","year":"2012","journal-title":"Methods Mol Biol"},{"issue":"1","key":"10.1016\/j.bjhh.2015.07.011_bib0465","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1200\/JCO.2000.18.1.43","article-title":"Randomized trial of filgrastim, sargramostim, or sequential sargramostim and filgrastim after myelosuppressive chemotherapy for the harvesting of peripheral-blood stem cells","volume":"18","author":"Weaver","year":"2000","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.bjhh.2015.07.011_bib0470","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.bbmt.2004.02.001","article-title":"Randomized comparison of granulocyte colony-stimulating factor versus granulocytemacrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma","volume":"10","author":"Arora","year":"2004","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"10.1016\/j.bjhh.2015.07.011_bib0475","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1365-2141.2006.06054.x","article-title":"Fixed-dose single agent pegfilgrastim for peripheral blood progenitor cell mobilisation in patients with multiple myeloma","volume":"133","author":"Hosing","year":"2006","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1016\/j.bjhh.2015.07.011_bib0480","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/bmt.2014.39","article-title":"Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation","volume":"49","author":"Mohty","year":"2014","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.bjhh.2015.07.011_bib0485","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/sj.bmt.1700867","article-title":"Comparison of peripheral blood progenitor cell mobilization in patients with multiple myeloma: high-dose cyclophosphamide plus GM-CSF vs G-CSF alone","volume":"20","author":"Alegre","year":"1997","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.bjhh.2015.07.011_bib0490","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1046\/j.1365-2141.2001.02498.x","article-title":"Preceding chemotherapy, tumour load and age influence engraftment in multiple myeloma patients mobilized with granulocyte colony-stimulating factor alone","volume":"112","author":"Desikan","year":"2001","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.bjhh.2015.07.011_bib0495","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3816\/CLM.2006.n.014","article-title":"Cyclophosphamide mobilization does not improve outcome in patients receiving stem cell transplantation for multiple myeloma","volume":"6","author":"Dingli","year":"2006","journal-title":"Clin Lymphoma Myeloma"},{"issue":"7","key":"10.1016\/j.bjhh.2015.07.011_bib0500","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1182\/blood.V98.7.2059","article-title":"Randomized trial of filgrastim versus chemotherapy and filgrastim mobilization of hematopoietic progenitor cells for rescue in autologous transplantation","volume":"98","author":"Narayanasami","year":"2001","journal-title":"Blood"},{"issue":"3\/4","key":"10.1016\/j.bjhh.2015.07.011_bib0505","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3109\/10428190009065829","article-title":"Is there any difference in PBPC mobilization between cyclophosphamide plus G-CSF and G-CSF alone in patients with non-Hodgkin's lymphoma?","volume":"39","author":"Dazzi","year":"2000","journal-title":"Leuk Lymphoma"},{"issue":"Suppl. 2","key":"10.1016\/j.bjhh.2015.07.011_bib0510","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1038\/sj.bmt.1701670","article-title":"Economic considerations in the use of peripheral blood progenitor cells to support high-dose chemotherapy","volume":"23","author":"Glaspy","year":"1999","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1016\/j.bjhh.2015.07.011_bib0515","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1080\/14653240701452800","article-title":"Intermediate-dose CY and GCSF more efficiently mobilize adequate numbers of PBSC for tandem autologous PBSC transplantation compared with low-dose CY in patients with multiple myeloma","volume":"9","author":"Hiwase","year":"2007","journal-title":"Cytotherapy"},{"issue":"7","key":"10.1016\/j.bjhh.2015.07.011_bib0520","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.bbmt.2012.01.005","article-title":"Intermediate-dose versus low-dose cyclophosphamide and granulocyte colony stimulating factor for peripheral blood stem cell mobilization in patients with multiple myeloma treated with novel induction therapies","volume":"18","author":"Hamadani","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"issue":"Suppl. 2","key":"10.1016\/j.bjhh.2015.07.011_bib0525","doi-asserted-by":"crossref","first-page":"S206","DOI":"10.1016\/j.bbmt.2009.12.161","article-title":"A comparison of toxicity and mobilization efficacy following two different doses of cyclophosphamide for mobilization of hematopoietic stem cells in non-Hodgkin's lymphoma patients","volume":"16","author":"Sizemore","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"10.1016\/j.bjhh.2015.07.011_bib0530","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.bbmt.2008.07.004","article-title":"Impact of mobilization and remobilization strategies on achieving sufficient stem cell yields for autologous transplantation","volume":"14","author":"Pusic","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"issue":"36","key":"10.1016\/j.bjhh.2015.07.011_bib0535","doi-asserted-by":"crossref","first-page":"6101","DOI":"10.1200\/JCO.2009.22.2554","article-title":"Immunochemotherapy and autologous stem-cell transplantation for untreated patients with mantle-cell lymphoma: CALGB 59909","volume":"27","author":"Damon","year":"2009","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.bjhh.2015.07.011_bib0540","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1182\/blood-2008-03-147025","article-title":"Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo epurged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group","volume":"112","author":"Geisler","year":"2008","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bjhh.2015.07.011_bib0545","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.transci.2009.05.011","article-title":"Management of poor peripheral blood stem cell mobilization: incidence, predictive factors, alternative strategies and outcome. A retrospective analysis on 2177 patients from three major Italian institutions","volume":"41","author":"Perseghin","year":"2009","journal-title":"Transfus Apher Sci"},{"issue":"12","key":"10.1016\/j.bjhh.2015.07.011_bib0550","first-page":"1532","article-title":"Successful peripheral blood stem cell harvesting with granulocyte colony-stimulating factor alone after previous mobilization failure","volume":"89","author":"Lefrere","year":"2004","journal-title":"Haematologica"},{"issue":"10","key":"10.1016\/j.bjhh.2015.07.011_bib0555","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/sj.bmt.1704486","article-title":"Analysis of remobilization success in patients undergoing autologous stem cell transplants who fail an initial mobilization: risk factors, cytokine use and cost","volume":"33","author":"Boeve","year":"2004","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1016\/j.bjhh.2015.07.011_bib0560","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1600-0609.2010.01520.x","article-title":"Mobilization strategies in hard-to-mobilize patients with lymphoid malignancies","volume":"85","author":"Jantunen","year":"2010","journal-title":"Eur J Haematol"},{"issue":"3","key":"10.1016\/j.bjhh.2015.07.011_bib0565","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/bmt.2011.82","article-title":"Proposed definition of \u2018poor mobilizer\u2019 in lymphoma and multiple myeloma: an analytic hierarchy process by ad hoc working group Gruppo ItalianoTrapianto di Midollo Osseo","volume":"47","author":"Olivieri","year":"2012","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.bjhh.2015.07.011_bib0570","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.bbmt.2008.11.028","article-title":"Treatment with plerixafor in non-Hodgkin's lymphoma and multiple myeloma patients to increase the number of peripheral blood stem cells when given a mobilizing regimen of G-CSF: implications for the heavily pretreated patient","volume":"15","author":"Stiff","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"10.1016\/j.bjhh.2015.07.011_bib0575","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1200\/JCO.2004.07.131","article-title":"Rapid mobilization of CD34+ cells following administration of the CXCR4 antagonist AMD3100 to patients with multiple myeloma and non-Hodgkin's lymphoma","volume":"22","author":"Devine","year":"2004","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.bjhh.2015.07.011_bib0580","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1182\/blood-2005-02-0468","article-title":"The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone","volume":"106","author":"Flomenberg","year":"2005","journal-title":"Blood"},{"issue":"28","key":"10.1016\/j.bjhh.2015.07.011_bib0585","doi-asserted-by":"crossref","first-page":"4767","DOI":"10.1200\/JCO.2008.20.7209","volume":"27","author":"DiPersio","year":"2009","journal-title":"J Clin Oncol"},{"issue":"23","key":"10.1016\/j.bjhh.2015.07.011_bib0590","doi-asserted-by":"crossref","first-page":"5720","DOI":"10.1182\/blood-2008-08-174946","article-title":"Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma","volume":"113","author":"DiPersio","year":"2009","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.bjhh.2015.07.011_bib0595","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.bbmt.2013.05.008","article-title":"Pharmacoeconomics of hematopoietic stem cell mobilization: an overview of current evidence and gaps in the literature","volume":"19","author":"Shaughnessy","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"12","key":"10.1016\/j.bjhh.2015.07.011_bib0600","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.bbmt.2009.08.005","article-title":"Successful stem cell remobilization using plerixafor (mozobil) plus granulocyte colony-stimulating factor in patients with non-Hodgkin lymphoma: results from the plerixafor NHL phase 3 study rescue protocol","volume":"15","author":"Micallef","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.bjhh.2015.07.011_bib0605","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.bbmt.2012.08.010","article-title":"Cost-effectiveness analysis of a risk-adapted algorithm of plerixafor use for autologous peripheral blood stem cell mobilization","volume":"19","author":"Micallef","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"10.1016\/j.bjhh.2015.07.011_bib0610","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/bmt.2011.133","article-title":"A risk-based approach to optimize autologous hematopoietic stem cell (HSC) collection with the use of plerixafor","volume":"47","author":"Abhyankar","year":"2012","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.bjhh.2015.07.011_bib0615","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/jca.21256","article-title":"An algorithm for utilizing peripheral blood CD34 count as a predictor of the need for plerixafor in autologous stem cell mobilization \u2013 cost-effectiveness analysis","volume":"28","author":"Abusin","year":"2013","journal-title":"J Clin Apher"},{"issue":"Suppl. 2","key":"10.1016\/j.bjhh.2015.07.011_bib0620","doi-asserted-by":"crossref","first-page":"S159","DOI":"10.1016\/j.bbmt.2010.12.030","article-title":"A cost effective analysis of a risk-adapted algorithm for plerixafor use in autologous peripheral blood stem cell mobilization","volume":"17","author":"Micallef","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"10.1016\/j.bjhh.2015.07.011_bib0625","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1111\/j.1537-2995.2011.03136.x","article-title":"Effectiveness and cost analysis of justin-time salvage plerixafor administration in autologous transplant patients with poor stem cell mobilization kinetics","volume":"51","author":"Li","year":"2011","journal-title":"Transfusion"},{"issue":"1","key":"10.1016\/j.bjhh.2015.07.011_bib0630","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1537-2995.2011.03206.x","article-title":"Efficacy and cost\u2013benefit analysis of risk-adaptive use of plerixafor for autologous hematopoietic progenitor cell mobilization","volume":"52","author":"Vishnu","year":"2012","journal-title":"Transfusion"},{"issue":"1","key":"10.1016\/j.bjhh.2015.07.011_bib0635","first-page":"33","article-title":"Economic evaluation of plerixafor for stem cell mobilization","volume":"18","author":"Kymes","year":"2012","journal-title":"Am J Manag Care"},{"issue":"9","key":"10.1016\/j.bjhh.2015.07.011_bib0640","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1038\/bmt.2009.370","article-title":"Clinical impact and resource utilization after stem cell mobilization failure in patients with multiple myeloma and lymphoma","volume":"45","author":"Gertz","year":"2010","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"10.1016\/j.bjhh.2015.07.011_bib0645","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/sj.bmt.1705298","article-title":"Poor mobilization is an independent prognostic factor in patients with malignant lymphomas treated by peripheral blood stem cell transplantation","volume":"37","author":"Pavone","year":"2006","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1016\/j.bjhh.2015.07.011_bib0650","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1080\/1042819031000067585","article-title":"Poor mobilization of peripheral blood stem cells is a risk factor for worse outcome in lymphoma patients undergoing autologous stem cell transplantation","volume":"44","author":"Gordan","year":"2003","journal-title":"Leuk Lymphoma"}],"container-title":["Revista Brasileira de Hematologia e Hemoterapia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S151684841500119X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S151684841500119X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,13]],"date-time":"2023-08-13T07:29:21Z","timestamp":1691911761000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S151684841500119X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":65,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S151684841500119X"],"URL":"https:\/\/doi.org\/10.1016\/j.bjhh.2015.07.011","relation":{},"ISSN":["1516-8484"],"issn-type":[{"value":"1516-8484","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hematopoietic progenitor cell mobilization for autologous transplantation \u2013 a literature review","name":"articletitle","label":"Article Title"},{"value":"Revista Brasileira de Hematologia e Hemoterapia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bjhh.2015.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Associa\u00e7\u00e3o Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Editora Ltda.","name":"copyright","label":"Copyright"}]}}